Introduction
Malformin A1 (MA1, Figure 1A ), ac yclic pentapeptide containing an intramolecular disulfide bond, produced by the filamentous fungus Aspergillusn iger,w as originally identified as at eratogenic substance for plants. [1] [2] [3] [4] In ap roject directed towards developing an ew thrombolytic agent,w er ediscovered MA1 in the course of screening low-molecular-weight compounds that enhancef ibrinolytic activity. [5] MA1 acts on urokinase-producing monocytes and increases cellular plasmina ctivity. [5, 6] A recent study also showed that the activation of RSK1 by way of the MAP kinase pathway leads to an increase in urokinase expression for fibrinolytic activity enhancement of MA1. [7] AlthoughM A1 exhibits undesirable cytotoxicity together with the enhancement of cellular fibrinolytic activity,o ur previous structure-activity relationship study for MA1 suggested that the cytotoxic effects of MA1 could be split from its fibrinolysisenhancing effect. [8] To understand the moleculars tructural characteristics that reduce MA1 cytotoxicity,i ti si mportant to Malformin A1 (MA1) is af ungus-produced cyclic pentapeptide. MA1 exhibits teratogenicity to plants, fibrinolysis-enhancingactivity,a nd cytotoxicity to mammalian cells. To clarify the cytotoxic mechanism of MA1, we screened for the genes involved in the cytotoxicity of MA1 in monocytoid U937 cells by using a CRISPR/Cas9-based genome-wide knockout library. Screening was performed by positive selection for cells that were resistant to MA1 treatment, and single guide RNAs (sgRNAs) integrated into MA1-resistant cells were analyzed by high-throughput sequencing.A saresult of the evaluation of sgRNAs that were enriched in MA1-resistant cells, SQLE,w hiche ncodes squalenee poxidase, was identified as ac andidate gene. SQLEdepletedU 937 cells were viable in the presence of MA1, and squalenee poxidasei nhibitor conferred MA1 resistance to wildtype cells. These resultsi ndicate that squalene epoxidase is implicated in the cytotoxicity of MA1. This finding represents an ew insight into applications of MA1 for treating ischemic diseases. clarify the mechanism of actioni nvolved in the expression of cytotoxicity.
In general, elucidation of the mechanisms of action of bioactive compounds is accompanied by difficulty.G enome-wide loss-of-function screening has proventobeapowerful and unbiased approach by which to gain insighti nto biology modulated by bioactive compounds. ComprehensiveR NA interference (RNAi)s creening had been established as as earching methodf or gene targets and the mechanisms of action of bioactive compounds. [9] [10] [11] In recent years, genome-wide knockout screening by using the clustered regularly interspaced short palindromer epeats (CRISPR)/Cas9g enome-editing technology has been developed. [12] [13] [14] These screening approaches are extremelye ffective in identifying-by meanso faproliferationbased assay-genes that confer ar esistance or sensitive phenotype to acytotoxic compound. [15, 16] Here, we attempted to screent he gene involved in MA1 cytotoxicity by using ag enome-wide CRISPR/Cas9 knockout lentivirus library to elucidate the mechanism of MA1 cytotoxicity. As ac onsequence, squalene epoxidase (SQLE, EC 1.14.14.17), an important enzyme in cholesterol biosynthesis, was identified as ag ene implicated in MA1 cytotoxicity.
Results and Discussion
As shown in the previousr eport, [8] MA1 exhibits cytotoxic properties against monocytoid U937 cells ( Figure 1B) . To clarify the mechanism of MA1 cytotoxicity,w et herefore attempted to perform genome-wide loss-of-function screening by utilizing CRISPR/Cas9 genome editing technology.Apooled genomescale CRISPR/Cas9 knockout (GeCKO) library,c omposed of a single lentiviral vector simultaneously delivering single guide RNAs (sgRNAs) and Cas9, was used for screening. [13, 17] The GeCKO library consistso f1 23 411s gRNAs targeting 19 052 genes in the human genome. The sgRNAs are designedt o target 5' constitutive exons and to minimize off-target effects. To identify gene knockouts that result in resistance to MA1 in U937 cells, we conducted positive selection screening to select for cells acquiring MA1 resistance with lentivirus-mediated Cas9/sgRNA transduction( Figure 1C ).
The concentration of MA1 used for screening (1 mm)w as set as the value that would ensure cell death of nontransduced cells during 7-14 dt reatment ( Figure 1B) . Treatment with MA1 resultedi ng rowth arrest of GeCKO-transduced U937 cells over 14 d ( Figure 2A ), thus suggesting that sgRNA/Cas9-mediated modification could enrich as mall group of cells resistant to MA1. When the candidate genes targeted by sgRNA that were enriched as compared to untreated control cell group were soughtb yn ext-generation sequencinga fter PCR amplification of the sgRNA sequence ( Figure S1 and Table S1 in the Supporting Information), the sgRNA distributions of the cells after 7 and 14 days of treatment with MA1 were found to be significantly different from those of untreated control cells (one-way analysiso fv ariance( ANOVA) with the Tukey post-hoc test, p = 0.026 and p < 0.0001, respectively,F igure2B). Figure 2C shows the scatter plots of each sgRNA read count between MA1-treated and untreated group. Each sgRNA was ranked by its differential abundance between the MA1-treated versus untreated populations ( Figure 2D ). Further, ao ne-sided twosample Kolmogorov-Smirnovt est was applied to calculate a p value for each gene to compare the sgRNAs targetingt he gene against the nontargeting control sgRNAs ( Figure 2E ). Twelve overlapping sgRNAs (RAB14, SQLE, MKNK1, DEGS1, ITCH, ORMDL3, RB1CC1, C15orf32, AP3B1, ABTB2, ATG16L1,a nd PPP1R14A)w ere present between the top 100 most enriched sgRNAsa te ach treatment point ( Figure 2F and G, and Ta ble S2).
Of these candidateg enes, SQLE,acholesterol biosynthesis enzyme, [18, 19] DEGS1,adesaturase involved in the formation of ceramide, [20] and ORMDL3,anegative regulator of sphingolipid synthesis, [21] are involved in lipid metabolism, and each gene product is localized in the endoplasmic reticulum (ER) membrane. RAB14,b elonging to the large RAB family of low-molecular-mass GTPases, [22] and AP3B1,asubunit of adaptor-related protein complex 3, [23] are involved in membrane trafficking, so these candidates might participate in the intracellular transport of MA1. Moreover,t wo autophagy-relatedg enes are also candidates: ATG16L1,acomponent of ATG12·ATG5·ATG16L1 complex involved in the autophagy process, [24] and RB1CC1,aregulator for membrane targeting of ATG16L1. [25] PPP1R14A,aregulatory subunit of protein phosphatase 1( PP1), might alsop articipate in autophagy as an inhibitor of PP1 involved in the inactivation of ATG16L1. [26, 27] MA1 has previously been reported to induce autophagic cell death, [28] so these genes might be involved in cell death due to MA1. Furthermore, two candidate genes are involved in the ubiquitin/proteasome system: ITCH, Itchy E3 ubiquitin protein ligase, [29] and ABTB2,a nkyrin repeat and BTB domain containing 2.
[30] MKNK1,M AP kinase signalintegrating kinase 1, encodes aS er/Thrk inase, [31] and C15orf32, chromosome 15 open readingf rame 32, encodes an uncharacterizedp rotein.
Our recent report showed that fluorescence-labeled MA1 was enriched in ER-like intracellular compartments, [7] so, out of the candidate genes, we focused on SQLE localized in ER membrane ( Figure 2G )a nd validated the effectso fd epletion by individual sgRNA transductiono nM A1 cytotoxicity in U937 cells. Protein expression levels of SQLE were depleted by about 70 % or more after sgRNA transduction ( Figure 3A) . Whereas control sgRNA-transduced cells were dead after 10 dM A1 treatment, the deletion of SQLE provided resistancet oM A1 cytotoxicity in U937 cells ( Figure 3B ). In addition, tolnaftate, an inhibitor of SQLE, [32] attenuated the MA1 cytotoxicity in as imilarw ay to SQLE depletion ( Figure 3C ). These findings indicated that SQLE is involvedi nt he expression of MA1 cytotoxicity.
This study demonstrated that SQLE deletion conferred resistance to MA1 cytotoxicity in U937 monocytoid cells, thus suggesting that SQLE might be at arget gene of MA1. SQLE is an endoplasmic reticulum membrane enzymei nvolved in cholesterol biosynthesis by catalyzing the conversion of squalene into (S)-2,3-epoxysqualene. [18, 19] It is as yet unknown whether MA1 acts directly on SQLE and inhibits enzymea ctivity.T he inhibition of SQLE leads to ad ecrease in cholesterol biosynthesis and to the accumulation of squalene, which might result in cell death.I ndeed, Sqle knockout mice are embryonic lethal, [33] ChemBioChem 2019, 20,1563 -1568 www.chembiochem.org 2019 The Authors. Publishedb yWiley-VCH Verlag GmbH &Co. KGaA, Weinheim and SQLE is considered to be essentialf or development and survival. In this study,t he cell proliferation of U937 cells was hardly affected by CRISPR/Cas9-induced depletion of SQLE ( Figure 3B ), which might possibly be compensated for by the transport of serum-derived cholesterol into the cells. Therefore, it is considered that MA1 does not inhibit the enzymatic activity of SQLE. Other genes in the cholesterol biosynthesis pathway were not found as high-ranking genes in this screening, so cholesterol biosynthesis might not be directly related to MA1 cytotoxicity ( Figure S2) . Rather,i ti sc onceivable that SQLE might be am odulator of MA1 cytotoxicity.W es peculate that SQLE might be involved in metabolizing MA1 into am ore toxic form. This hypothesis is supported by the fact that the SQLE inhibitor counteracted the cytotoxicity of MA1 (Figure 3C) . However,i nv iew of the partial but not complete rescue of MA1 cytotoxicity by SQLE sgRNA or TNF,w ea ssume that other genes including RAB14 are also involved in MA1 cytotoxicity.
We originally identified MA1 as af ibrinolysis-enhancing agent, so the cytotoxic effect is considered to be an undesirable side effect. Recent reports,h owever,f ocus on the cytotoxic effect of MA1 and its analogues,a nd malformins have been reevaluateda sa ntitumor agents. [28, 34, 35] In investigations of the mechanism of action of MA1 cytotoxicity on prostate cancer cells, oxidative stress and mitochondrial damage were reported to induce cell death. [28] In addition, MA1 has been reported to upregulate the phosphorylation of stress-activated kinase p38 followed by induction of apoptosis in colorectal cancer cells. [35] In this anticancer activity,S QLE might be associated with the cytotoxice ffect of MA1. In summary,w eh ave found, by use of genome-wide CRISPR/Cas9 screening, that SQLE is implicated in the cytotoxicity of MA1. This finding might provide new insight into applications of MA1 to treat ischemic diseases such as myocardial infarction and cerebral infarction.
Experimental Section
Reagents and cell culture:M A1 was isolated from culture broth of A. niger F7586 according to the previous report. [6] Briefly, A. niger F7586 was grown by static culture at 25 8Cf or 6d.T he obtained mycelial cake was extracted with methanol. The concentrated extract was re-extracted with ethyl acetate. MA1 was partially purified by silica gel column chromatography and finally purified by preparative reversed-phase HPLC. The purity of MA1 was > 99 %. The human GeCKOv2 CRISPR knockout pooled library was ag ift from Feng Zhang (Addgene, cat# 1000000048). U937 cells (JCRB, Japan, cat# IFO50 038) were cultured in RPMI-1640 containing fetal bovine serum (FBS, 10 %), penicillin (100 units mL À1 ), and streptomycin (100 mgmL
À1
). 293FT cells were obtained from Thermo Fisher Scientific (cat# R70007) and were cultured in complete medium consisting of Dulbecco'sm odified Eagle'sm edium (DMEM), FBS (10 %), lglutamine (6 mm), non-essential amino acids (0.1 mm), sodium pyruvate (1 mm), penicillin (100 units mL À1 ), and streptomycin (100 mgmL À1 ). Cells were cultured under humidified CO 2 (5 %) at 37 8C.
MTT assay:C ytotoxicity was evaluated by means of the MTT assay. U937 cells were either passaged or replaced with fresh medium with vehicle or MA1 (1 mm)e very 3-4 d. After the treatment period, MTT (Sigma-Aldrich) was added to each well, followed by incubation for 4h.A fter incubation, each well received extraction solution, containing DMF (40 %), CH 3 COOH (2 %), HCl (0.03 m), and SDS (20 %), and was thoroughly mixed by agitation overnight at room temperature. Cytotoxicity was evaluated by measuring the absorbance at 570 nm with amicroplate reader (Bio-Rad, USA).
Genome-wide loss-of-function screening
Lentivirus production:T op roduce lentivirus, 293FT cells were seeded in 12 100 mm dishes at % 25 %c onfluence the day before transfection. Prior to transfection, media were replaced with fresh media. Transfection was performed with FuGENE HD (Promega). For each dish, FuGENE HD (50 mL) was added to Opti-MEM (Thermo Fisher Scientific, 800 mL) with GeCKOv2 plasmid library (8.5 mg), pMD2.G (Addgene, cat# 12 259, 4.25 mg), and psPAX2 (Addgene, cat# 12260, 4.25 mg). The mixture was incubated for 15 min before being added to cells. After 12 h, the medium was replaced with fresh medium. After 48 h, the supernatants containing viral particles were harvested and filtrated through am embrane (0.45 mmp ore).
Cell transduction of the GeCKOv2 library:T ot ransduce the GeCKOv2 library,U 937 cells were seeded in ten 100 mm dishes (4 10 6 per dish), and the cells in each dish were transduced with virus supernatant (5 mL) at am ultiplicity of infection (MOI) of 0.5. After 24 h, each medium was replaced with fresh medium containing puromycin (2 mgmL À1 ). Puromycin selection was carried out for 4d.
MA1-resistance screen:P uromycin-selected transduced U937 cell cultures were each divided into two fractions. One fraction (3.5 10 7 cells) was frozen down as an untreated day 0s ample for genomic DNA analysis in each case, and the other (1.4 10 8 cells) was treated with MA1 (1 mm)f or 7d.T reated cells were either passaged or replaced with fresh medium containing MA1 every 2-3 d. After 7d,t he cells were further divided into two fractions. One fraction (6.2 10 7 cells) was frozen down as ad ay 7s ample, and the other (2.2 10 7 cells) was treated with MA1 for an additional 7d.A fter treatment, the cells (7.4 10 7 cells) were frozen down as ad ay 14 sample.
Genomic DNA sequencing:F rozen cell pellets were thawed, and genomic DNA was extracted from 1 10 7 cells in DNA extraction buffer containing Tris·HCl (pH 9.0, 50 mm), EDTA( 20 mm), NaCl (40 mm), SDS (1 %), and proteinase K( 0.5 mg mL À1 )a t5 5 8Co vernight. The extracted DNA was precipitated with isopropanol and washed with ethanol (70 %). For next-generation sequencing (NGS) analysis, PCR was performed in two steps. For the first PCR, to amplify sgRNA integrated into genomic DNA, genomic DNA (60-70 mgp er sample) was used, and 12-14 separate reaction mixtures (50 mL) with genomic DNA (5 mgi ne ach case) were subjected to PCR with ExTaq HS polymerase (TaKaRa, Japan). The resulting amplicons were combined for as econd PCR reaction. The first PCR primer sequences are:f wd:5 '-AATGG ACTAT CATATG CTTAC CGTA ACTTG AAAGT ATTTC G-3',r ev:5 '-TCTAC TATTC TTTCC CCTGC ACTGT TGTGG GCGATG TGCG CTCTG-3'.F or the second PCR, to attach Illumina adaptors and barcodes, reaction mixtures (100 mL) TGACT GGAGT TCAGA CGTGT GCTCT TCCGA TCTTC TACTAT TCTT  TCCCC TGCAC TGT-3' .F or the second PCR fwd primer,avariablelength sequence and an 8bpb arcode were included to increase library complexity and to provide multiplicity of different biological samples, respectively.F or both PCR reactions, 20 amplification cycles were performed. Second PCR amplicons were gel-extracted, quantified, mixed, and sequenced by using aH iSeq 2000 instrument (Illumina, USA).
CRISPR/Cas9-induced SQLE depletion:O ligonucleotides for SQLE sgRNA (Table S3) were annealed and cloned into lentivirus transfer vector lentiCRISPRv2 (Addgene, cat# 52961) at the restriction site of BsmBI. [17] For production of recombinant lentivirus particles, confluent 293FT cells (80 %) were transfected in a6 -well plate with FuGENE HD mixture containing transfer plasmid, pMD2.G, and psPAX2. After 12 h, the medium was replaced with fresh medium. After 48 h, the supernatants containing viral particles were harvested and filtrated through am embrane (0.45 mmp ore). For each viral construct, U937 cells (1 10 6 )w ere transduced in a6 -well plate with medium containing viral supernatant (1 mL). At 48 h post-transduction, puromycin selection for obtaining SQLE-depleted cells was carried out for 4d.
Western blot analysis:T he membrane fraction of sgRNA/Cas9-transduced U937 cells was isolated by using aS ubcellular Protein Fractionation Kit (Thermo Fisher Scientific, cat# 78840). After determination of protein concentration, equal amounts of protein were subjected to SDS-PAGE under reducing conditions. After electrophoresis, proteins were transferred to an itrocellulose membrane. Membranes were blocked with skim milk (5 %) and then incubated with mouse monoclonal antibodies against SQLE (Santa Cruz Biotechnology,c at# sc-271651) and SQS (Santa Cruz Biotechnology, cat# sc-271602). After washing, the membranes were incubated with HRP-conjugated anti-mouse IgG antibody (GE Healthcare, cat# NA931). Subsequently,t argeted proteins were detected by using an ECL Prime system (GE Healthcare, cat# RPN2232).
Cell viability test:s gRNA/Cas9-transduced U937 cells (4 10 5 cells) were plated into 24-well plates with vehicle (DMSO), or MA1 (1 mm) and/or tolnaftate (Sigma-Aldrich, 1 mm). Treated cells were either passaged or replaced with fresh medium with vehicle or drugs every 3-4 d. At each time point, the viable cell number was counted by trypan blue exclusion.
